2014
DOI: 10.1016/j.vph.2014.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Vascular effects of the Mediterranean diet Part I: Anti-hypertensive and anti-thrombotic effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 89 publications
(140 reference statements)
2
15
0
Order By: Relevance
“…Consumption of EVOO enhanced the production of coagulation factors and intermediate disease markers for platelet aggregation, such as activated factor VII and plasminogen activator inhibitor-1 (Ruano et al, 2007). Moreover, a MUFA-rich diet seems to reduce coagulation factor VIIc in the postprandial status (Capurso, Massaro, Scoditti, Vendemiale, & Capurso, 2014 ingredients such as proteins and fibre affect the composition of the microbiome, including synthesis and release of metabolites modulating the immune system and inflammation (Clemente, Ursell, Parfrey, & Knight, 2012;Richards, Yap, McLeod, Mackay, & Mariño, 2016). In this context, the presence as well as the absence of effectors can be of importance.…”
Section: Haemostasis Platelet Aggregation and Coagulationmentioning
confidence: 94%
See 1 more Smart Citation
“…Consumption of EVOO enhanced the production of coagulation factors and intermediate disease markers for platelet aggregation, such as activated factor VII and plasminogen activator inhibitor-1 (Ruano et al, 2007). Moreover, a MUFA-rich diet seems to reduce coagulation factor VIIc in the postprandial status (Capurso, Massaro, Scoditti, Vendemiale, & Capurso, 2014 ingredients such as proteins and fibre affect the composition of the microbiome, including synthesis and release of metabolites modulating the immune system and inflammation (Clemente, Ursell, Parfrey, & Knight, 2012;Richards, Yap, McLeod, Mackay, & Mariño, 2016). In this context, the presence as well as the absence of effectors can be of importance.…”
Section: Haemostasis Platelet Aggregation and Coagulationmentioning
confidence: 94%
“…Consumption of EVOO enhanced the production of coagulation factors and intermediate disease markers for platelet aggregation, such as activated factor VII and plasminogen activator inhibitor‐1 (Ruano et al, ). Moreover, a MUFA‐rich diet seems to reduce coagulation factor VIIc in the postprandial status (Capurso, Massaro, Scoditti, Vendemiale, & Capurso, ). Two short‐term RCTs investigating the effects of oleic acid or phenolic rich EVOO reported an attenuation of the pro‐thrombotic state in the postprandial phase (Delgado‐Lista, Garcia‐Rios, Perez‐Martinez, Lopez‐Miranda, & Perez‐Jimenez, ; Pacheco, Lopez, Bermudez, Abia, & Muriana, ).…”
Section: Pharmacological Mechanism—ingredientsmentioning
confidence: 99%
“…Olive oil is a very flavor-stable oil because of the high oleic fatty acid content (70-80%) (O'Brien 2009; Criado et al, 2008). Moreover, interest in oleic acid as a healthpromoting nutrient has expanded in recent years (Capurso et al, 2014;Sales-Campos et al, 2013). Studies using animal cells have shown that oleic acid enhanced intra-cellular levels of lipid peroxidation, indicating that the acid can promote good adaptive response and increase the tolerance of the cells by increasing antioxidant capacity (Haeiwa et al, 2014).…”
Section: Fatty Acid Compositionsmentioning
confidence: 99%
“…In the latter cases, AF may also have no strict temporal relationship with stroke, which may be causally related to atheroemboli from the aorta or carotid arteries or even from a calcified aortic stenosis or calcified mitral annulus (58-61) (Figure 3). In this latter perspective, the complexity of the mechanisms of atherothrombosis and the number of factors modulating this process are well known (62)(63)(64). Despite these data, indicating that AF may play a "dual role" with regard to stroke/thromboembolism,, it is important to stress that independently on considerations and assessments of the actual role of AF (as a risk factor for cardioembolism or as a marker of vascular risk) prophylaxis with an oral anticoagulant (apixaban) resulted superior to aspirin in preventing the end point of stroke (ischemic or hemorrhagic) or systemic embolism in a randomized double-blind trial (65).…”
Section: Accepted Manuscriptmentioning
confidence: 99%